Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5‐hydroxytryptamine receptor (type 3) antagonist
The DOI matches its Crossref record.
Abstract
SUMMARY: Ondansetron (GR38032F) is a selective antagonist of 5‐hydroxytryptamine (5‐HT) type 3 receptors. This randomized, doubleblind, cross‐over study was undertaken to evaluate and compare the effect of ondansetron with placebo on gastrointestinal transit in 10 healthy male volunteers. There were no significant differences between the effects of placebo and ondansetron on gastric emptying or mouth‐to‐caecum transit time. However, significant differences in mean whole‐gut transit time were observed, that is 54.8 h with ondansetron and 32.1 h with placebo. Therefore, 5‐HT 3 receptors may be involved in the regulation of colonic transit and ondansetron may prove useful as an anti‐diarrhoeal agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Camilleri, M., Northcutt, A. R., Kong, S., Dukes, G. E., McSorley, D., & Mangel, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02033-x · Cited by 556
Serotonin: A Mediator of The Brain–Gut Connection
Kim, D.-Y., & Camilleri, M. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03177.x · Cited by 448
Camilleri, Mayer, Drossman, Heath, Dukes, Mcsorley, Kong, Mangel, & Northcutt (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00610.x · Cited by 369
Dunlop, S. P., Jenkins, D., & Spiller, R. C. (2003) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07542.x · Cited by 359
Bearcroft, C. P., Perrett, D., & Farthing, M. J. G. (1998) · Gut · doi:10.1136/gut.42.1.42 · Cited by 303
Metadata
- Authors
- GORE, S., GILMORE, I. T., HAIGH, C. G., BROWNLESS, S. M., STOCKDALE, H., & MORRIS, A. I.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 1990-04
- Volume
- 4
- Issue
- 2
- Pages
- 139-144
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2158025174
- Cited by
- 109
- References
- 0
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5‐hydroxytryptamine receptor (type 3) antagonist. https://app.cochat.ai/papers/10.1111/j.1365-2036.1990.tb00458.x
- The paper
- GORE, S., GILMORE, I. T., HAIGH, C. G., BROWNLESS, S. M., STOCKDALE, H., & MORRIS, A. I. (1990). Colonic transit in man is slowed by ondansetron (GR38032F), a selective 5‐hydroxytryptamine receptor (type 3) antagonist. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.1990.tb00458.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.